Adenosine 5’-Monophosphate Protects from Hypoxia by Lowering Mitochondrial Metabolism and Oxygen Demand

• Published in: Shock (Augusta, Ga.) Ga.), 2020-08, Vol.54 (2), p.237-244
• Main Authors: Kondo, Yutaka, Sueyoshi, Koichiro, Zhang, Jingping, Bao, Yi, Li, Xiaoou, Fakhari, Mahtab, Slubowski, Christian J., Bahrami, Soheyl, Ledderose, Carola, Junger, Wolfgang G.
• Format: Article
• Language: English
• ISSN: 1073-2322; 1540-0514
• DOI: 10.1097/SHK.0000000000001440

ABSTRACTIschemia and reperfusion injury following severe trauma or cardiac arrest are major causes of organ damage in intensive care patients. The brain is particularly vulnerable because hypoxia rapidly damages neurons due to their heavy reliance on oxidative phosphorylation. Therapeutic hypothermia can reduce ischemia-induced brain damage, but cooling procedures are slow and technically difficult to perform in critical care settings. It has been previously reported that injection of naturally occurring adenosine 5’-monophosphate (AMP) can rapidly induce hypothermia in mice. We studied the underlying mechanisms and found that AMP transiently reduces the heart rate, respiratory rate, body temperature, and the consciousness of adult male and female C57BL/6J mice. Adding AMP to mouse or human neuronal cell cultures dose-dependently reduced the membrane potential (ΔΨm) and Ca signaling of mitochondria in these cells. AMP treatment increased intracellular AMP levels and activated AMP-activated protein kinase, which resulted in the inhibition of mammalian target of rapamycin complex 1 (mTORC1) and of mitochondrial and cytosolic Ca signaling in resting and stimulated neurons. Pretreatment with an intraperitoneal injection of AMP almost doubled the survival time of mice under hypoxic (6% O2) or anoxic (